Bertesi, M., L. Tavernari, A. Neroni, E. Papa, S. Rontauroli, E. Bianchi, M. Mirabile, R. Norfo, S. Parenti, C. Tombari, C. Carretta, M. Malerba, L. Fabbiani, P. Guglielmelli, L. Losi, E. Tagliafico, A. M. Vannucchi, and R. Manfredini. 2026. “P007 | Pre-Clinical Efficacy of a Novel Combined Pharmacological Approach Targeting JAK and ERK in a Myelofibrosis Mouse Model: M. Bertesi1|3, L. Tavernari1|2, A. Neroni1|3, E. Papa1|3, S. Rontauroli1|2, E. Bianchi1|3, M. Mirabile1|2, R. Norfo1|2, S. Parenti1|2, C. Tombari1|2, C. Carretta1|2, M. Malerba1|3, L. Fabbiani4, P. Guglielmelli5|6, L. Losi4, E. Tagliafico7|8, A. M. Vannucchi5|6, R. Manfredini1|2 | 1Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia; 3Department of Life Sciences, University of Modena and Reggio Emilia; 4Pathology Unit , Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; 5CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi; 6Department of Experimental and Clinical Medicine, University of Florence; 7Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; 8Department of Laboratory Medicine, Diagnostic Hematology and Clinical Genomics Unit, Modena University Hospital”. Haematologica 111 (s1). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s1.80.